Form 4 Filing for 10x Genomics, Inc.

This filing details a transaction by Shehnaaz Suliman, a director at 10x Genomics, Inc. On June 4, 2026, Suliman acquired 8,829 shares of Class A Common Stock. The transaction code "A" indicates an acquisition, and the price per share was $0.00. Following this transaction, Suliman holds a total of 37,445 shares. The filing also includes a Power of Attorney document, appointing Randy Wu and James Bryant as attorneys-in-fact to handle electronic filings with the SEC and execute necessary forms (3, 4, and 5) on Suliman's behalf. This Power of Attorney remains in effect until Suliman is no longer required to file these forms or until it is revoked.